Reply To: CSAM Health Group AS (Ticker: CSAM)
Carmenta-aqcuisition:
CSAM adding 81MNOK in sales, EBITDA-margin of 12.3% and price paid is EV/Sales 1.85. Carmenta will be included in the “Emergency & Acute” segment. Will most likely have a negative impact on margins in the short-term since the”buy-integrate-build”- model takes approximately 1 year (ref Arcid and Kibi acquisitions in 2019).
About Carmenta: Link
From press release: Link
CSAM Health Group AS acquires Carmenta’s Public Safety Business (closing 15 February 2021)
Carmenta Public Safety reported annual sales of ca 81 MSEK in 2020 with a corresponding EBITDA of > 10 MSEK.
The acquisition is based on an agreed enterprise value of 150 MSEK on a cash-free and debt-free basis implying an EV/sales multiple of 1.85x based on 2020 reported figures. The acquisition will be settled in cash.
